Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | AMGN | BMY | GILD | VRTX |
| Company | Merrimack Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 12.75 | 264.74 | 49.06 | 74.85 | 347.50 |
| High | 12.85 | 267.50 | 49.35 | 75.45 | 353.58 |
| Low | 12.75 | 263.50 | 48.67 | 74.68 | 346.68 |
| Last | 12.85 | 267.09 | 49.10 | 74.89 | 352.83 |
| Change | +0.07 | +1.57 | +0.18 | +0.38 | +5.79 |
| % Change | +0.55% | +0.59% | +0.37% | +0.51% | +1.67% |
| Volume | 1,810 | 792,413 | 4,150,182 | 1,702,308 | 624,095 |
| 20-Day Average Volume | 40,380 | 2,114,422 | 13,567,660 | 6,218,148 | 1,480,297 |
| Previous Close | 12.78 | 265.52 | 48.92 | 74.51 | 347.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.58 | 267.23 | 50.56 | 76.72 | 363.26 |
| 20-Day Raw Stochastic | 89.47% | 58.31% | 10.82% | 10.58% | 24.79% |
| 20-Day Relative Strength | 61.45% | 49.40% | 33.54% | 44.65% | 46.53% |
| Weighted Alpha | +10.03 | -0.14 | -40.96 | -14.80 | +10.47 |
| Today's Opinion | 100% Buy | 40% Buy | 100% Sell | 88% Sell | 40% Buy |
| Previous Opinion | 100% Buy | 40% Buy | 100% Sell | 88% Sell | 24% Buy |
| Last Month's Opinion | 64% Buy | 56% Buy | 100% Sell | 8% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.63% since 11/21/23 | +1.46% since 11/21/23 | +1.02% since 11/21/23 | +0.28% since 11/21/23 | -0.45% since 11/21/23 |
| Low | 12.75 on 11/29/23 | 261.66 on 11/27/23 | 48.56 on 11/22/23 | 74.19 on 11/28/23 | 346.29 on 11/28/23 |
| High | 12.95 on 11/24/23 | 267.50 on 11/29/23 | 49.91 on 11/24/23 | 75.99 on 11/24/23 | 358.50 on 11/22/23 |
| 1-Month | |||||
| %Chg | +4.81% since 10/27/23 | +1.95% since 10/27/23 | -4.01% since 10/27/23 | -2.24% since 10/27/23 | -0.59% since 10/27/23 |
| Low | 12.00 on 11/07/23 | 249.70 on 10/31/23 | 48.42 on 11/20/23 | 73.99 on 11/16/23 | 341.90 on 11/16/23 |
| High | 12.95 on 11/24/23 | 274.95 on 11/06/23 | 53.55 on 11/06/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 3-Month | |||||
| %Chg | +4.22% since 08/29/23 | +2.71% since 08/29/23 | -22.08% since 08/29/23 | -4.23% since 08/29/23 | +0.55% since 08/29/23 |
| Low | 12.00 on 11/07/23 | 248.38 on 09/06/23 | 48.42 on 11/20/23 | 72.87 on 10/03/23 | 340.83 on 09/06/23 |
| High | 12.95 on 11/24/23 | 288.46 on 10/13/23 | 63.03 on 08/30/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| 6-Month | |||||
| %Chg | +2.80% since 05/26/23 | +22.93% since 05/26/23 | -23.26% since 05/26/23 | -2.84% since 05/26/23 | +7.03% since 05/26/23 |
| Low | 11.53 on 07/19/23 | 211.71 on 06/01/23 | 48.42 on 11/20/23 | 72.87 on 10/03/23 | 320.01 on 06/01/23 |
| High | 12.95 on 11/24/23 | 288.46 on 10/13/23 | 66.46 on 06/05/23 | 82.59 on 11/03/23 | 387.42 on 11/06/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 183,022 | 142,100,448 | 99,540,360 | 92,842,592 | 89,426,320 |
| Shares Outstanding, K | 14,321 | 535,178 | 2,034,758 | 1,246,042 | 257,683 |
| Annual Sales | 0 | 26,323,000,000 | 46,159,000,000 | 27,281,000,000 | 8,930,700,000 |
| Annual Net Income | -1,540,000 | 6,552,000,000 | 6,327,000,000 | 4,592,000,000 | 3,322,000,000 |
| Last Quarter Sales | 0 | 6,903,000,000 | 10,966,000,000 | 7,051,000,000 | 2,483,500,000 |
| Last Quarter Net Income | -280,000 | 1,730,000,000 | 1,928,000,000 | 2,180,000,000 | 1,035,300,000 |
| 60-Month Beta | 1.65 | 0.58 | 0.38 | 0.32 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/02/23 | 4.96 on 10/31/23 | 2.00 on 10/26/23 | 2.29 on 11/07/23 | 4.08 on 11/06/23 |
| Latest Earnings Date | 11/02/23 | 10/31/23 | 10/26/23 | 11/07/23 | 11/06/23 |
| Most Recent Dividend | N/A | 2.130 on 11/16/23 | 0.570 on 10/05/23 | 0.750 on 09/14/23 | N/A |
| Next Ex-Dividends Date | 05/30/17 | 11/16/23 | 10/05/23 | 12/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.66 | 6.43 | 11.23 | 26.53 |
